Marshall Wace’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
276,795
+211,707
+325% +$7.61M 0.01% 969
2026
Q1
$2.09M Sell
65,088
-392,807
-86% -$14.4M ﹤0.01% 1756
2025
Q4
$17.6M Sell
457,895
-553,011
-55% -$12.1M 0.02% 669
2025
Q3
$13.9M Buy
1,010,906
+785,537
+349% +$9.22M 0.01% 802
2025
Q2
$2.91M Buy
225,369
+10,484
+5% +$109K ﹤0.01% 1393
2025
Q1
$2.42M Buy
+214,885
New +$2.82M ﹤0.01% 1395
2024
Q4
Sell
-9,500
Closed -$380K 3079
2024
Q3
$380K Sell
9,500
-15,354
-62% -$558K ﹤0.01% 2033
2024
Q2
$733K Buy
+24,854
New +$677K ﹤0.01% 1813

Other funds holding PACS

Marshall Wace's PACS Position: Q2 2026 in Review

Marshall Wace increased its PACS Group (PACS) stake by 325% in Q2 2026, buying an estimated $7.61M and bringing the position to 276,795 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #969.

Marshall Wace first reported a position in PACS in Q2 2024 and has held it in 8 quarters since. The position peaked at $17.6M in Q4 2025. 178 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Marshall Wace held 276,795 shares of PACS Group worth $11.8M as of Q2 2026.
  • Marshall Wace bought 211,707 PACS Group shares in Q2 2026, an estimated $7.61M.
  • PACS Group made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #969 holding.
  • Marshall Wace first reported a position in PACS Group in Q2 2024 and has held it in 8 quarters since.
  • Marshall Wace's PACS Group position peaked at $17.6M in Q4 2025.
  • 178 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.